# Oral Topotecan to Treat Recurrent or Persistent Solid Tumors

> **NCT00382733** · PHASE1,PHASE2 · COMPLETED · sponsor: **Accelerated Community Oncology Research Network** · enrollment: 26 (actual)

## Conditions studied

- Tumors

## Interventions

- **DRUG:** Oral Topotecan

## Key facts

- **NCT ID:** NCT00382733
- **Lead sponsor:** Accelerated Community Oncology Research Network
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-11
- **Primary completion:** 2011-03
- **Final completion:** 2011-03
- **Target enrollment:** 26 (ACTUAL)
- **Last updated:** 2013-07-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00382733

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00382733, "Oral Topotecan to Treat Recurrent or Persistent Solid Tumors". Retrieved via AI Analytics 2026-06-30 from https://api.ai-analytics.org/clinical/NCT00382733. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*